The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
Autor: | Graziano, E., Peghin, M., De Martino, M., De Carlo, C., Da Porto, A., Bulfone, L., Casarsa, V., Sozio, E., Fabris, M., Cifù, A., Grassi, B., Curcio, F., Isola, M., Sechi, L. A., Tascini, C., Croatto, L., Ditaranto, P., Ditaranto, L. M., GIRA-COVID study group |
---|---|
Rok vydání: | 2022 |
Předmět: |
Adult
Aged 80 and over Male Metabolic Syndrome Sarcopenia Nutrition and Dietetics Obesity paradox SARS-CoV-2 Endocrinology Diabetes and Metabolism Bioimpedance analysis Abdominal Fat COVID-19 Middle Aged Body Mass Index BMI Waist circumference Obesity Abdominal Body Composition Humans Female Obesity Prospective Studies Aged |
Zdroj: | Clinical nutrition ESPEN. 51 |
ISSN: | 2405-4577 |
Popis: | Obesity has been described as a predisposing risk factor to severe forms of COVID-19, but conflicting results are emerging on its real impact on the mortality of COVID-19. We aimed to compare clinical outcomes and mortality among COVID-19 patients according to obesity, metabolic syndrome and adiposity distribution.We conducted a prospective observational study of all consecutive adult patients with a confirmed diagnosis of SARS-CoV-2 infection admitted to the Infectious Diseases Clinic at Udine Hospital, Italy, from January 2021 to February 2021. At admission, the study population was submitted to specific anthropometric, laboratory and bioimpedance analysis (BIA) measurements and divided into five groups according to: 1) BMIor30 kg/mA total of 195 patients were enrolled in the study. The mean age of patients was 71 years (IQR 61-80) and 64.6% (126) were male. The most common comorbidities were hypertension (55.9%) and MS (55.4%). Overall mortality was 19.5%. Abdominal adiposity, measured both with WC and with BIA, and SP were significantly associated with need for increased ventilator support (p = 0.013 for WC; p = 0.037, 0.027 and 0.009 for VAT; p = 0.004 and 0.036 for FMI; and p = 0.051 for SP), but not with ICU admission (WC p = 0.627, VAT p = 0.153, FMI p = 0.519 and SP p = 0.938), length of stay (WC p = 0.345, VAT p = 0.650, FMI p = 0.159 and SP p = 0.992) and mortality (WC p = 0.277, VAT p = 0.533, FMI p = 0.957 and SP p = 0.211). Obesity and MS did not discriminate for the intensity of ventilatory outcome (p = 0.142 and p = 0.198, respectively), ICU admission (p = 0.802 and p = 0.947, respectively), length of stay (p = 0.471 and p = 0.768, respectively) and mortality (p = 0.495 and p = 0.268, respectively). We did not find significant differences in inflammatory markers and secondary complications within the five groups.In patients admitted with COVID-19, increased WC, visceral abdominal fat and SP are associated with higher need for ventilatory support. However, obesity, MS, SP and abdominal adiposity are not sensitive predictive factors for mortality. |
Databáze: | OpenAIRE |
Externí odkaz: |